Charu Arora

  • 1st Year GS

Why did you choose the University of Pittsburgh?

University of Pittsburgh was of great interest to me for graduate school due to the reowned faculty working in the field of cancer immunology and additionally as a Pitt Alumni I was eager to come back to Pitt as I had a fanatastic experience here as a undergrad. 

Education & Training

  • MS in Biomedical Sciences, Thomas Jefferson University, 2023
  • BS in Chemistry, University of Pittsburgh, 2019

Research Interest Summary

Immunology, cancer immunotherapy, translational medicine

Publications

Vivien I. Maltez, Charu Arora*, Rina Sor, Qiaoshi Lian, Robert H. Vonderheide, Ronald N. Germain, Katelyn T. Byrne. Agonistic anti-CD40 converts Tregs into Type 1 effectors within the tumor micro- environment. Under review. bioRxiv 2022.10.17.512537; doi: https://doi.org/10.1101/2022.10.17.512537

Samuel I. Kim, Charu Arora*, Kyle Gribbin, Francisco Hernandez, Ioannis I. Verginadis, Christopher R. Cassella, Nune Markosyan, Jinyang Li, Constantinos Koumenis, Ben Z. Stanger, Robert H. Vonderheide, Katelyn T. Byrne. CD4 T cells mediate rejection of MHC I deficient tumor cells. Manuscript in preparation.

Nune Markosyan, Charu Arora*, Liz Quinones, Il-Kyu Kim, John Tobias, Nikhil Joshi, Ben Z. Stanger, Robert H. Vonderheide. Disruption of Prostaglandin E2 Receptor EP4 signaling to suppress pancreatic cancer growth. Manuscript in preparation.

Shreya Ghosh, Joshua Casto, Xiaowei Bogetti, Charu Arora*, Junmei Wang, Sunil Saxena. (2020). Orientation and dynamics of Cu2+ based DNA labels from force field parameterized MD elucidates the relationship between EPR distance constraints and DNA backbone distances. Phys. Chem. Chem. Phys., 22(46), 26707– 26719. https://doi.org/10.1039/D0CP05016D